CPHI Frankfurt to Show Innovations Driving Pharma Manufacturing Efficiency and Compliance

CPHI Frankfurt is scheduled to convene from Oct. 28–30, 2025. As a key highlight in the industry’s annual calendar, this event serves as a crucial forum for the entire pharmaceutical supply chain, offering key insights into technological advancements designed to enhance process control, patient safety, and efficiency.

The industry is rapidly embracing solutions for complex challenges, including the need for greater automation in biopharmaceutical production, reliable material performance in continuous manufacturing environments, and stricter regulatory compliance. Concurrently, efforts to meet growing sustainability mandates are driving innovation in both packaging and formulation.

These pivotal developments highlight a trajectory toward greater scalability and integrity in modern drug production. The following is a compilation of recent company news detailing innovations and exhibits to be shown at the conference.

BENEO’s excipient supports continuous manufacturing

The pharmaceutical-grade isomalt excipient galenIQ™ will be presented as a compelling binder solution for continuous manufacturing, delivering robust granule formation and high-strength tablets while maintaining rapid disintegration (1). This non-synthetic, plant-based filler-binder also provides formulators with process control and consistency, while its pleasant taste enhances patient compliance for oral dosage forms.

Eckelmann enhances biopharma automation and scalability

Eckelmann is offering customized control systems and specialized artificial intelligence vision capabilities from a single source, aimed at accelerating biopharmaceutical production capacity and reducing operating costs (2). The utilization of digital twins for simulating test runs and commissioning saves time and money, enabling maximum plant availability and optimization of key performance indicator monitoring.

IMA advances aseptic filling and continuous OSD lines

IMA Life is introducing TILE-X, a fully gloveless solution for filling small-batch ready-to-use high-value products, such as cell and gene therapies, ensuring maximum sterility and operator safety compliant with Annex 1 good manufacturing practice (GMP) guidelines (3). Separately, IMA Active is cultivating expertise, including a partnership with CONTINUUS Pharmaceuticals, to advance continuous manufacturing lines for the compression and coating of oral solid dosage forms.

BD and partners debut unit-level syringe traceability

A joint demonstration will showcase an end-to-end workflow for unit-level traceability in injectable drug manufacturing using the BD iDFill RFID Integration Tour, tracking syringes from filling through assembly (4). This radio frequency identification-enabled system supports improved efficiency, deviation management, and adherence to increasingly strict regulatory expectations for product integrity and quality.

SÜDPACK medica unveils recyclable blister concepts

The PharmaGuard blister concept is a pioneering polypropylene-based mono-material solution that achieves high recyclability and a significantly lower climate impact compared with conventional multilayer structures. This innovation aligns with growing industry pressure for sustainable plastic film solutions while meeting necessary current GMP requirements for oral solid doses.

Click here for all of our CPHI Frankfurt coverage.

References

1. BENEO. CPHI 2025: BENEO to Present galenIQ As the Granulation Binder of Choice. Press Release. Sept. 24, 2025.
2. Eckelmann Group. From a Single Source: Hardware and Software for Efficiency in Biopharmaceutical Production Capacities. Press Release. Oct. 13, 2025.
3. IMA Group. IMA Pharma and IMA MED-TECH at CPHI Frankfurt 2025. Press Release. Oct. 16, 2025.
4. ten23 health. BD, ten23 health, and Partners to Demo Full RFID Syringe Traceability at CPHI Frankfurt. Press Release. Oct. 15, 2025.
5. SÜDPACK Medica. Sustainable Innovations and Valuable Insights: SÜDPACK Medica at CPHI. Press Release. Oct. 13, 2025.